A phase 2 study shows promising benefits and safety with a new leadless pacemaker, delivering effective right ventricular pacing with a retrievable device.
As part of a global clinical trial, the Clinic has successfully implanted the novel device, which integrates wireless communication between leadless pacing and defibrillator therapy.